The effect of cotrimoxazole coadministrated with antituberculous drugs on serum transaminases in HIV-infected adults from the Ivory Coast.
作者信息
Messou E, Anglaret X, Bonard D, Kouabena H, N'Dri-Yoman T, Dosso M, Dabis F
出版信息
Br J Clin Pharmacol. 2001 Nov;52(5):611-2. doi: 10.1046/j.0306-5251.2001.01483.x.
Abstract
摘要
相似文献
1
The effect of cotrimoxazole coadministrated with antituberculous drugs on serum transaminases in HIV-infected adults from the Ivory Coast.
Br J Clin Pharmacol. 2001 Nov;52(5):611-2. doi: 10.1046/j.0306-5251.2001.01483.x.
2
3
Dietary problems in African HIV-1-infected adults, Abidjan, Côte d'Ivoire. COTRIMO-CI Study Group.
J Acquir Immune Defic Syndr. 2000 Apr 1;23(4):357-8. doi: 10.1097/00126334-200004010-00014.
4
18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Côte d'Ivoire: a cohort study.
BMC Public Health. 2008 May 20;8:169. doi: 10.1186/1471-2458-8-169.
5
Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Côte d'Ivoire.
Antivir Ther. 2005;10(5):615-24. doi: 10.1177/135965350501000510.
6
Pattern of bacterial diseases in a cohort of HIV-1 infected adults receiving cotrimoxazole prophylaxis in Abidjan, Côte d'Ivoire.
AIDS. 2003 Mar 7;17(4):575-84. doi: 10.1097/00002030-200303070-00013.
7
Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire.
N Engl J Med. 2006 Sep 14;355(11):1141-53. doi: 10.1056/NEJMsa060247.
8
Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group.
Lancet. 1999 May 1;353(9163):1463-8. doi: 10.1016/s0140-6736(98)07399-1.
9
Cotrimoxazole prophylaxis in adults infected with HIV in low-income countries.
Curr Opin Infect Dis. 2001 Oct;14(5):507-12. doi: 10.1097/00001432-200110000-00002.
10
[Compliance in HIV infected adults. Study of opportunistic infection prophylaxis with cotrimoxazole in Ivory Coast].
Presse Med. 2004 May 22;33(9 Pt 1):595-600. doi: 10.1016/s0755-4982(04)98683-6.
本文引用的文献
1
Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial.
Lancet. 1999 May 1;353(9163):1469-75. doi: 10.1016/s0140-6736(99)03465-0.
2
Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group.
Lancet. 1999 May 1;353(9163):1463-8. doi: 10.1016/s0140-6736(98)07399-1.
3
Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus.
Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1871-6. doi: 10.1164/ajrccm.157.6.9711039.
4
Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone.
N Engl J Med. 1990 Sep 20;323(12):776-82. doi: 10.1056/NEJM199009203231202.
Zotero 插件